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Objectives: to evaluate preoperative clinical, surgical and instrumental variables as predictors of postoperative cardiac
events in patients undergoing different types of elective major vascular surgery.
Material and methods: on the basis of an algorithm including clinical and test echocardiographic data, we prospectively
stratified 604 consecutive patients into low, intermediate and high-risk groups. The value of the variables in predicting
postoperative cardiac events was assessed by means of multivariate analysis.
Results: there were 16 major postoperative cardiac events and six of 16 postoperative deaths were cardiac related (1%).
Significant predictors of cardiac complications were unrecognised myocardial infarction (odds ratio – (OR) 5.6), coronary
artery disease (OR 2.5), severe hypertension (OR 2.1) and peripheral vascular surgery (OR 1.9). In the intermediate-risk
group, the best correlates with cardiac complications were unrecognised myocardial infarction (OR 3.3) and diabetes (OR
2.5).
Conclusions: our results suggest the importance of identifying patients with unrecognised ischaemic heart disease and
of using aggressive perioperative protocols for managing diabetic patients undergoing peripheral vascular procedures.
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Introduction scintigraphy,4–8 exercise,9 Holter monitoring10 and do-
butimine stress echocardiography11 have been pro-
Postoperative cardiac complications represent a major posed as offering incremental value when assessing
preoperative cardiac risk.element of vascular surgical risk, and depend on
patient and procedure-related risk factors. In the pre- However, recent studies have questioned the value
of such provocative tests11–14 on the grounds of theoperative assessment of low and intermediate-risk
surgical procedures, the cardiac-risk indexes used over efficacy of clinical cardiac-risk indexes in stratifying
low and high-risk patients, and the inadequacy ofthe last 20 years are generally effective in suggesting
risk-reduction strategies, including cancelling the pro- stress testing for assessing cardiac risk in intermediate-
risk patients.14cedure. However, in the case of high-risk procedures,
the severity of the vascular disease itself often reduces The present study was prospectively designed to
reassess the role of clinical and surgical properativethe opportunities for risk reduction in patients in
whom the presence of many coronary artery disease- variables as predictors of postoperative cardiac events
in a population of patients stratified into low, inter-related determinants would otherwise suggest the ad-
option of a conservative management policy. mediate and high-risk groups on the basis of a pre-
viously validated algorithm including clinical and restOn the basis of these considerations, and the ob-
servation that coronary artery disease is the leading echocardiographic data14 (Table 1). Although our algo-
rithm is very similar to that recently proposed by thecause of mortality and morbidity after vascular sur-
gery,1–3 various tests such as dipirydamole thallium AHA/ACC task-force,15 it differs insofar as it suggests
the use of resting echocardiographic evaluation in all
except low-risk patients as a means of exploring the
possibility of myocardial revascularisation in those
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Table 1. Cardiac risk assessment.
Low risk Intermediate risk High risk
Age Ζ70 yrs: Age >70 yrs and/or: LVEF <50% and/or:
Normal ECG Angina CCS I/II Angina CCS III–IV
No coronary artery disease Diabetes mellitus CHF
Mild hypertension Previous M.I. ([6 months) Previous M.I. (<6 months)
LVEF [50%
ECG: electrocardiogram.
CCS: Canadian Cardiovascular Society Classification.
M.I.: myocardial infarction.
LVEF: left ventricular ejection fraction.
CHF: congestive heart failure.
ricular function and, given the high incidence of cor- disagreement between the echocardiographic and ECG
onary artery disease and diabetes mellitus in patients findings were not considered as having an un-
undergoing vascular surgery,16 of evaluating the pres- recognised myocardial infarction.
ence of silent heart disease in those with abnormal Angina was defined as chest pain having at least
ECG findings. three of the following characteristics: a substernal loca-
tion, precipitation by stress, a duration of less than
15 min and resolution after rest or nitroglycerine. It
was graded using the Canadian Cardiovascular Society
Methods Classification (CCS).
Congestive heart failure was diagnosed on the basis
Patients of previous episodes of pulmonary oedema or clinical
evidence of related signs and symptoms.
Six hundred and fourteen consecutive patients referred Diabetes mellitus was diagnosed on the basis of the
to the Department of Vascular Surgery of Niguarda revised criteria of United States National Diabetes
Hospital for elective vascular surgery were pro- Data Group of the National Institutes of Health, and
spectively studied over a 4-year period. Informed con- classified as type 1 insulin-dependent and immune-
sent was obtained and the protocol was approved by mediated; type 2 non-insulin dependent and immune
the local Ethics Committee. mediated; type 2 non-insulin dependent and non-
immune mediated.
Severe hypertension was defined as a diastolic blood
pressure of 110 mmHg or more treated with two or
Clinical data more drugs.
Chronic obstructive pulmonary disease (COPD) was
Previous myocardial infarction was diagnosed on the diagnosed on the basis of clinical evidence including
basis of clinical history and electrocardiographic (ECG) chest X-ray, spirometry and blood-gas exchange ana-
evidence of Q waves with a depth of at least 1 mm lysis. The patients were stratified into low, inter-
and lasting at least 0.04 s according to the Minnesota mediate and high-risk groups on the basis of
Code criteria. previously reported clinical criteria13,15,17,18 using a pre-
In the absence of a history of acute myocardial viously validated algorithm (Table 1).
infarction, angina or congestive heart failure, un-
recognised myocardial infarction was defined as ECG
evidence of Q waves with the above characteristics or
negative T waves, with echocardiographic wall motion
abnormalities occurring in the same coronary territory:
Echocardiography(1) hypokinesis: reduced endocardial excursion and/
or systolic wall thickening; (2) akinesis: no endocardial
Rest echocardiography (Acuson 128 XP 10 C, Mountainexcursion and/or systolic wall thickening (3) dys-
View, California) was performed in all intermediatekinesis: paradoxical systolic wall motion. Ventricular
and high-risk patients 1–10 days before surgery usingwall areas showing reduced diastolic thickness
American Society of Echocardiography standard para-(Ζ6 mm) and increased echoreflectivity were con-
sidered scar tissue. The patients in whom there was a meters.20
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Type of surgical procedure successive daily 12-lead electrocardiograms; (2) minor
arrhythmias, defined as unsustained and clinically
Four procedures were considered: aortic (thoraco-ab- uncomplicated tachyarrhythmias.
Regional left ventricular function impairment wasdominal and abdominal aneurysms, aorto-bifemoral
bypass, aorto-visceral artery bypass), peripheral echocardiographically assessed as standard clinical
practice in order to clarify all postoperative ischaemic(femoro-popliteal and femoro-distal bypass and pro-
fundoplasty), carotid (carotid endoarterectomy) and or haemodynamic disorders.
miscellaneous (iliaco-femoral endoarterectomy or by-
pass and extra-anatomic bypass).
Statistical analysis
The continuous values are expressed as meanPerioperative management
values±SD. One-way ANOVA was used to compare
the estimates of the continuous variables in the threeGeneral, thoracic epidural or local analgesia (carotid
endoarterectomy) was used. Haemodynamic moni- risk groups, and contingency table analysis to compare
categorical variables. Univariate analysis (Biomedicaltoring was used for selected high-risk patients. Beta-
blockers were not routinely used. Following cardiac Computer Program, Statistical Software INC., Los An-
geles, CA, U.S.A.) was performed to determine therisk stratification, individual tailoring of the cardiac
and surgical management was allowed in high-risk significant predictors in the study population as a
whole, and in the intermediate and high-risk groups.patients.
The variables that proved to be significant predictors
in the study population as a whole and in the inter-
mediate-risk patients were then entered into a step-
Postoperative management wise logistic regression model in order to determine
the multivariate predictors of adverse cardiac events. A
Twelve-lead ECG recordings and cardiac enzyme probability value of <0.05 was considered significant.
measurements (creatine kinase and MB isoenzyme)
were repeated in all patients during the immediate
postoperative period and daily until discharge.
Results
A total of 614 patients were enrolled over a period of
Clinical outcomes 4 years. The vascular procedure was subsequently
cancelled in 10 high-risk patients, and so the study
The primary outcomes were overall mortality and population comprised 604 patients of a mean age
major cardiac complications: (1) death unrelated to (±SD) of 64±11 years (Tables 2 and 3). Prior to surgery,
other non-cardiac diseases occurring within 30 days 18 high-risk patients underwent non-invasive cardiac
of the surgical procedure; (2) myocardial infarction, evaluation, 31 coronary angiography and ten myo-
defined as autopsy evidence, new ECG Q waves of at cardial revascularisation. There were three sim-
least 1 mm in depth and lasting at least 0.04 s, or ultaneous coronary artery by-pass graft (CABG) and
persistent ST-segment depression associated with an carotid endoarterectomy (CEA), six CABG and one
increase in serum creatine kinase/MB isoenzyme to percutaneous transluminal coronary angioplasty
[20 ng per millilitre); (3) congestive heart failure, (PTCA). Two hundred and thirty-four patients under-
defined as pulmonary rales and orthopnea, classical went aortic, 150 peripheral, 106 carotid and 54 mis-
chest-film changes, or a pulmonary-capillary wedge cellaneous procedures. Eleven high-risk patients
pressure persistently greater than 18 mmHg in patients underwent anatomical bypass.
undergoing haemodynamic monitoring; (4) major
arrhythmias, defined as ventricular tachycardia or
atrial fibrillation and/or bradyarrhythmias leading to
low-output syndrome. Clinical outcomes
The secondary outcomes were minor cardiac com-
plications: (1) myocardial ischaemia, defined as a new Of the 16 major events (Table 4), four occurred during
surgery (two cases of ventricular tachycardia, oneST-T abnormality (ST depression [1 mm 60 ms after
the J point or T wave inversion) on at least two myocardial infarction, one cardiogenic shock), eight
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Table 2. Preoperative clinical and anamnestic data; all patients and risk groups.
All patients Low risk Intermediate risk High risk
(n=604) (n=161) (n=354) (n=89)
Age (years) 67±9 63±5 69±10 67±9
Sex (M/F) 485/119 130/31 278/76 77/12
Hypertension [2 drugs 221 (36%) 30 (20%) 140 (39%) 51 (57%)
Diabetes mellitus 122 (20%) — 105 (30%) 17 (19%)
Previous M.I. 168 (29%) — 105 (30%) 63 (70%)
Unrecognised M.I. 22 (4%) — 14 (4%) 8 (9%)
Angina 65 (11%) — 34 (10%) 21 (23%)
CHF 10 (2%) — — 10 (11%)
Arrhythmia 43 (7%) — 36 (10%) 7 (8%)
LVEF <50% 46 (8%) — — 46 (8%)
<35% 19 (3%) — — 19 (3%)
Serum creatinine (mg/dl) 1.34±0.94 1.15±0.79 1.33±0.77 1.70±1.61
M.I.: myocardial infarction.
CHF: congestive heart failure.
LVEF: left ventricular ejection fraction.
To convert creatinine values to micromoles per litre, multiply by 88.4.
Table 3. Preoperative clinical and anamnestic data: surgical subgroups.
Aortic Peripheral CEA Miscellaneous p value
(n=234) (n=150) (n=166) (n=54)
Age (years) 68.2±7.2 66±10 67.4±9.5 64.7±9.1 n.s.
Low-risk 68 (29%) 39 (26%) 37 (23%) 17 (31%) n.s.
Intermediate-risk 134 (57%) 88 (59%) 107 (64%) 25 (46%) n.s.
High-risk 32 (14%) 23 (15%) 22 (13%) 12 (22%) n.s.
Sex (M/F) 213/21 113/37 117/49 42/12 0.0001†
Hypertension ([2 drugs) 93 (40%) 52 (35%) 57 (34%) 19 (35%) n.s.
Diabetes mellitus 23 (10%) 61 (41%) 32 (19%) 6 (11%) 0.0001†
Angina 96 (41%) 55 (36%) 67 (40%) 20 (37%) n.s.
M.I. 66 (28%) 42 (28%) 45 (27%) 15 (28%) n.s.
Unrecognised M.I. 7 (3%) 9 (6%) 5 (3%) 1 (2%) n.s.
CHF 3 (1%) 2 (1%) 3 (2%) 2 (4%) n.s.
Arrhythmia 21 (9%) 12 (8%) 9 (5%) 1 (2%) n.s.
COPD 35 (15%) 6 (4%) 11 (7%) 8 (15%) 0.001†
LVEF 60±9 57±9 58±9 55±10 n.s.
Serum creatinine (mg/dl) 1.46±1.09 1.37±1.07 1.21±.42 1.38±1.25 n.s.
CAD: coronary artery disease.
M.I.: myocardial infarction.
CHF: congestive heart failure.
COPD: chronic obstructive pulmonary disease.
LVEF: left ventricular ejection fraction.
CEA: carotid endoarterectomy.
† Significant p value between all groups.
To convert creatinine values to micromoles per litre, multiply by 88.4.
the day after the surgical procedure (six myocardial myocardial infarction and one of congestive heart
failure.infarctions, two pulmonary oedemas), two after 3 days
(two myocardial infarctions), one after 10 days (pul- There was a significant difference in major events
between the low, intermediate and high-risk patients,monary oedema) and one after 14 days (sudden death
at home). The great majority of the minor cardiac as well as between the aortic, peripheral and carotid
procedures (Table 5). Of the 23 patients with pre-complications (ECG negative T waves) occurred dur-
ing the first two postoperative days. surgical unrecognised myocardial infarction, 14 were
stratified to the intermediate and nine to the high-riskTen of the 16 deaths were non-cardiac (1.6%): three
patients died of multiple organ failure, one of massive group. In one high-risk patient the surgical procedure
was completed. Of the 14 intermediate-risk patients,pulmonary embolism, one of stroke, one of septic
shock, two of intestinal infarction, one of respiratory two suffered myocardial infarctions (one cardiac
death); of the eight high-risk patients, one sufferedfailure and one of haemorrhagic hypovolaemia. The
cardiac mortality rate was 1%: five patients died of myocardial infarction (complicated by pulmonary oed-
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Table 4. Overall and cardiac mortality by risk group and vascular was 9% (2/22) and the major cardiac event rate 18%
procedure. (4/22).
Overall mortality Cardiac mortality
Low-risk 2 (1.2%) —
Univariate analysis(161 pts)
Intermediate-risk 6 (1.7%) 2 (0.6%)
(354 pts) Among the patients as a whole, the preoperative vari-High-risk 8 (9%) 4 (4.5%)
ables significantly associated with a major adverse(89 pts)
Total 16 (2.6%) 6 (1%) cardiac outcome in the univariate analysis were un-
recognised myocardial infarction, diabetes mellitus,p value=0.0009
previous myocardial infarction, hypertension, angina,
a left ventricular ejection fraction of less than 50% and
Aortic 10 (4.2%) 2 (0.85%) peripheral vascular surgery. In the intermediate-risk(234 pts)
patients they were unrecognised myocardial in-Peripheral 4 (2.6%) 2 (1.3%)
(150 pts) farction, previous myocardial infarction and diabetes
CEA 2 (1.2%) 2 (1.2%) mellitus. In the high-risk group no preoperative vari-(166 pts)
able was associated with postoperative cardiac out-Miscellaneous — —
(54 pts) comes.
Total 16 (2.6%) 6 (1%)
p value=n.s.
Multivariate analysisCEA: carotid endarterectomy.
The results of the logistic regression analysis of theTable 5. Minor and major postoperative cardiac events by risk
group and vascular procedure. patients as a whole and in the intermediate-risk group
are shown in Table 6. The preoperative predictors ofMinor events Major events
cardiac complications in the patients as a whole were
Low-risk 9 (5.5%) — unrecognised myocardial infarction, coronary artery
(161 pts) disease, severe hypertension and peripheral vascularIntermediate-risk 43 (12.1%) 7 (2%)
surgery; in the intermediate-risk patients they were(354 pts)
High-risk 8 (9%) 8 (9%) unrecognised myocardial infarction and diabetes.
(89 pts) The cardiac complication rate was 5% in the inter-All patients 60 (9.9%) 15 (2.5%)
mediate-risk patients with unrecognised myocardial(604 pts)
infarction and diabetes mellitus undergoing peripheral
p value=0.0001∗ vascular surgery (71 patients, 12%).
Aortic 37 (16%) 5 (2.1%)
(234 pts)
DiscussionPeripheral 11 (7%) 8 (5.3%)
(150 pts)
CEA 5 (3%) 2 (1.2%) The main finding of this study is that unrecognised(166 pts)
myocardial infarction, a history of coronary arteryMiscellaneous 7 (18.5%) —
(54 pts) disease, severe hypertension and peripheral vascular
Total 60 (9.9%) 15 (2.5%) surgery are predictors of postoperative adverse cardiac
outcomes in patients undergoing major vascular sur-p value=0.0001∗
gery. Furthermore, the algorithm including clinical
CEA: carotid endoarterectomy. and rest echocardiographic variables is adequate for∗Distribution of events between risk groups and type of surgical
the stratification of patients into risk groups withprocedure: significant p value between all groups (chi square ana-
lysis). significant differences in postoperative events.
Minor events: myocardial ischaemia, minor arrhythmias.
Major events: death, myocardial infarction, congestive heart failure,
major arrhythmias.
Low risk group
ema), one congestive heart failure (one cardiac death)
and one multiorgan failure (one non-cardiac death). Although the algorithm considered age as one of the
discriminant variables for statifying low-risk patients,In this subgroup of patients, the cardiac mortality rate
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Table 6. Multivariate analysis: independent predictors of major cardiac events.
All patients Intermediate-risk group
Odds ratio p value Odds ratio p value
(95% CI) (95% CI)
Unrecognised M.I. 5.6 (2.2–13.9) <0.001 3.31 (1.3–8.9) <0.05
CAD 2.5 (1.1–5.3) <0.001 — —
Hypertension 2.1 (1.1–3.8) <0.05 — —
Peripheral surgery 1.9 (1.0–1.3) <0.05 — —
Diabetes mellitus — — 2.5 (1.1–5.7) <0.05
M.I.: myocardial infarction.
CAD: coronary artery disease (including angina, known previous MI).
CI: confidence interval.
its irrelevance as a predictor of postoperative events procedure) to the presence of unstable necrotic tissue
and residual ischaemic myocardium. As unrecognisedsuggests its re-evaluation in patients undergoing vas-
cular surgery who have a normal electrocardiogram myocardial infarction is a relevant predictor of post-
operative cardiac events, we suggest undertaking aand no other predictors of events.
careful resting ECG and rest echocardiographic evalu-
ation of intermediate and high-risk patients. Where
scar tissue is present (reduced regional wall thickness
Intermediate-risk group and echocardiographic hyper-reflectivity), myocardial
revascularisation is ineffective and so we suggest ag-
In the patients with preserved left ventricular function, gressive perioperative management in an intensive
previously unrecognised myocardial infarction and care unit. In the case of two adjacent hypokinetic
diabetes mellitus were the only two predictors of segments indicating hybernating myocardium, we
postoperative events. We assessed unrecognised myo- suggest coronary angiography to explore the pos-
cardial infarction by means of echocardiographic sibility of myocardial revascularisation with the aim
regional wall motion analysis and ECG criteria using a of reducing the ischaemic burden and improving left
prospective design and a continuous cohort of patients. ventricular function before vascular surgery.
The epidemiological Reykjavik study21 of a population
sample of 9141 men reported a 31% incidence of
unrecognised myocardial infarction, closely correlated
High-risk groupwith age (5% in the group aged 75–79 years). In
agreement with these data, Lumley observed an in-
In these patients, the observation that no clinical orcidence of 33% in a selected cohort of patients under-
surgical variable per se is a predictor of cardiac eventsgoing exercise testing with myocardial perfusion
suggests a synergistic interpolation between the se-imaging, with a significant correlation with diabetes;
verity of cardiac disease and advanced muti-organhowever, the retrospective design of the study and the
disease as a possible explanation of the higher in-small sample of patients precluded a more exhaustive
cidences of adverse outcomes. Of the 31 patients under-evaluation of the clinic and anamnestic variables.
going coronary angiography to explore the possibilityOur patients with electrocardiographic evidence of
of myocardial revascularisation before vascular sur-Q waves or an ischaemic pattern such as negative T
gery, only 10 had an adequate anatomical conditionwaves were carefully investigated in terms of symp-
allowing them to undergo cardiac surgery or PTA.toms and a history of heart disease, and underwent
regional wall motion analysis. In the intermediate-
risk group, we found that unrecognised myocardial
infarction is a predictor of postoperative adverse car- Type of vascular surgery
diac outcomes (O.R 3.31) regardless of the type of
surgery, or clinical variables such as diabetes or hyper- The known association between diabetes and peri-
pheral vascular surgery,16 was confirmed in our study,tension. The incremental risk of postoperative cardiac
events related to unrecognised myocardial infarction and probably explains the role of peripheral surgery
as a predictor of an adverse cardiac outcome. Diabetesmay be due to the severity of the extent of coronary
artery disease or (given the unpredictability of the was an independent predictor only in the intermediate-
risk patients, probably because of the presence of othertime interval between the acute event and the surgical
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associated diseases in the high-risk group. The results Patients with electrocardiographic and rest echo-
cardiographic evidence of unrecognised myocardialof other studies are in partial agreement with our
findings.22,23 Krupski et al.22 reported a perioperative infarction are at the highest risk of postoperative car-
diac events. Definite clinical evidence of coronary ar-morbidity rate of 25% and 8% in patients undergoing
infrainguinal or aortic surgery, a difference that was tery disease, severe hypertension and peripheral
vascular surgery are important preoperative predictorsmainly attributed to concomitant cardiac or diabetic
factors. L’Italien et al.23 reported that patients under- of adverse cardiac outcomes; in the intermediate-risk
group, diabetes mellitus and unrecognised myocardialgoing infrainguinal procedures had a more than
doubled risk of perioperative myocardial infarction infarction are predictors of postoperative events.
than those undergoing aortic surgery, but this dif-
ference was reduced to insignificant levels after ad-
justment for comorbid factors. In our study, the
incremental value of diabetes and peripheral surgery Acknowledgements
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